The 13% return this week takes Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) shareholders three-year gains to 60%

Investing in index funds provides market returns easily. However, some prefer building their own portfolios for higher returns. Kiniksa Pharmaceuticals International (NASDAQ:KNSA) grew 60% over three years, outperforming the market.